Fundraising FoxKadence Bio
1 known investors
Find your way into Kadence Bio
Sign up to see every warm intro you have to Kadence Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kadence Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Kadence Bio is a clinical-stage life sciences company developing therapeutics for conditions in sexual and mental health. Its lead asset, KH-001, is being developed as an FDA-approved treatment for premature ejaculation, alongside a pipeline of compounds targeting mood disorders.
Investors · 1
Frequently asked questions
- What does Kadence Bio do?
- Kadence Bio is a clinical-stage life sciences company developing therapeutics for conditions in sexual and mental health. Its lead asset, KH-001, is being developed as an FDA-approved treatment for premature ejaculation, alongside a pipeline of compounds targeting mood disorders.
- Who are Kadence Bio's investors?
- Kadence Bio's investors include Palo Santo VC.